Linkedin and Facebook

The Chiesi UK LinkedIn and Facebook pages are designed for sharing information, news and events relating to the world of health or to Chiesi. We are delighted that you are in touch with us on these channels and hope that we can develop a fruitful and stimulating dialogue together.

We encourage thoughtful and respectful dialogue, and we value your input.

Due to the highly regulated nature of the pharmaceutical industry, we are not permitted to deal with certain topics online. In line with ABPI Code of Practice, pharmaceutical companies are prohibited from promoting prescription only medicines to the public.

We would also like to ensure that any dialogue started on our LinkedIn or Facebook page is constructive and remains on-topic. Comments therefore will not be answered and may be deleted from the company page if they:

• could be deemed as promoting our products;
• are defamatory, denigrating, offensive, vulgar, obscene or discriminatory;
• contain threats or violence or relate to illegal behaviour;
• contain information that is false, inaccurate, deceiving or not relevant for the purposes of the conversation being held;
• are off-topic and unrelated to Chiesi;
• contain medical or health advice;
• contain personal information such as names and surnames of third parties, email addresses or telephone numbers;
• contain confidential and sensitive information;
• contain information which may violate third party intellectual property or copyrights;
• relate to commercial offers or are designed to attract new fans/followers;
• contain excessively repetitive information, which may constitute spam for the Community;
• do not respect the terms of LinkedIn or Facebook

Our LinkedIn and Facebook account is regularly monitored and updated from Monday to Friday between 8:30-5:00pm. Comments and questions posted outside this timeframe will receive a reply the next working day.

UK-CHI-2500063 | January 2025